- State of the market: Are generic drugs approaching their peak?
- Cardinal Health invites independent pharmacy owners to ‘discover new horizons’ at RBC 2013
- Switch, new launches to bring resurgence
- Walgreens names former AstraZeneca exec corporate VP, market access to shepherd managed market strategies
- Kathleen Sebelius cites pharmacists' importance as Rite Aid CEO introduces Obamacare resource program
PEAPACK, N.J. — Greenstone has introduced an authorized generic treatment for breast cancer, the generics subsidiary of Pfizer said.
The company announced the launch of exemestane tablets, an authorized generic version of Pfizer’s Aromasin. Aromasin is used to treat early breast cancer in menopausal women who already have taken the drug tamoxifen for two to three years, as well as breast cancer in women whose disease has worsened while taking tamoxifen, which is widely available as a generic.
Authorized generics are branded drugs sold under their generic names at a reduced price.